What is Alchemab Therapeutics worth?
$138.0Mlast known valuation
Alchemab Therapeutics last raised $31.9M in its Later Stage VC (Series A) (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Alchemab Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Later Stage VC (Series A) | $31.9M | ▮ | ▮ |
How Alchemab Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Alchemab Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Alchemab Therapeutics worth?
- Alchemab Therapeutics's last known valuation is $138.0M.
- How much has Alchemab Therapeutics raised?
- Alchemab Therapeutics has raised $32.1M in total funding across 1 recorded rounds.
- When did Alchemab Therapeutics last raise?
- Alchemab Therapeutics last raised in Sep 2025 (Later Stage VC (Series A)), raising $31.9M.